Discharge FGF23 levels predicts one year outcome in patients admitted with acute heart failure

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Associate Professor Giuseppe Vergaro

Sant'Anna School of Advanced Studies, Pisa (Italy)

4 More presentations in this session

Presentation thumbnail

Additive prognostic value of cardiac biomarkers in patients with chronic obstructive pulmonary disease and heart failure

Doctor G. Vergaro (Pisa, IT)

Abstract Slides Video

Presentation thumbnail

Urate lowering therapy is associated with a lower risk of heart failure hospitalisation or mortality in hyperuricaemic patients with heart failure: a comparative effectiveness study

Doctor S. Kiddle (Cambridge, GB)

Abstract Slides Video

Presentation thumbnail

Cysteine-rich angiogenic inducer 61 (CCN1) independently predicts all-cause mortality in patients with dilated cardiomyopathy

Doctor R. Klingenberg (Frankfurt, DE)

Abstract Slides Video

Presentation thumbnail

Endotrophin is significantly associated with disease severity and increased risk of adverse outcome in HFpEF but not in HFrEF patients

Doctor A. Reese-Petersen (Copenhagen, DK)

Abstract Slides Video

Access the full session

Session thumbnail

Biomarkers to improve prognostication in heart failure: what's new?

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Congress Presentation

The role of a multimarker panel in the diagnosis and prognosis of patients with acute heart failure

Congress Presentation

Novel concepts in the diagnosis of AHF in the emergency department

Congress Presentation

Growth differentiation factor 15 and absorption loss as new biomarkers of heart failure decompensation

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources